Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 3, 1996, Pages 1244-1256

  Reid, Malcolm S ^a   Hsu, Kang ^a   Tolliver, Bryan K ^a   Crawford, Cynthia A ^a   Berger, S Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030111374     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. AKIMOTO, K., HAMAMURA, T. AND OTSUKI, S.: Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis. Brain Res. 490; 339-344, 1989.
2. ANDERSON, M P. AND WELSH, M. J.: Fatty acids inhibit apical membrane chloride channels in airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 87: 7334-7338, 1990.
3. 2- influx in cultured neurons. Brain Res. 586: 72-77, 1992.
4. BEN-SHAHAR, O AND ETTENBERG, A.: Repeated stimulation of the ventral tegmental area sensitizes the hyperlocomotor response to amphetamine. Pharmacol. Biochem. Behav. 48: 1005-1009, 1994.
5. BILLAH, M. M., LAPENITA, E G. AND CUATRECASAS, P.: Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets. J. Biochem. 256: 5399-5403, 1981.
6. BLACKWELL, G. J., DUNCOMBE, W. G., FLOWER, R. J., PARSONS, M. F. AND VANE, J. R.: The distribution and metabolism of araehidonic acid in rabbit platelets during aggregation and its modification by drugs. Br. J. Pharmacol. 59: 353-366, 1977.
7. CATANIA, M V., HOLLINGSWORTH, Z., PENNEY, J. B AND YOUNG, A. B.: Phospholipase A2 modulates different subtypes of excitatory amino acid receptors: Autoradiographic evidence. J. Neurochem. 60: 236-245, 1993.
8. +)-ATPaSe activity in brain slices and synaptosomes arachidonic acid. J. Neurochem. 40: 309-316, 1983.
9. CHURCHILL, P. C., ROSSI, N. F., CHURCHILL, M. C AND ELLIS, V. R.: Effect of melittin on renin and prostaglandin E2 release from rat renal cortical slices. J. Physiol. (Lond.) 428: 233-241, 1990.
10. COLLINRIDGE, G L., KEHL, S. J AND MCLENNAN, H.: The antagonism of amino acid-induced excitations of rat hippocampal CA1 neurones in vitro. J. Physiol. (Lond.) 334: 19-31, 1983.
11. COSTALL, B. AND NAYLOR, R. J.: Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavioral patterns and hyperactivity by amphetamine and apomorphine in the rat. In Cocaine and Other Stimulants, ed. by E. H. Ellinwood and M. M. Kilby, pp. 47-76, Plenum Press, New York, 1977.
12. 3H]AMPA binding to a putative homomeric GluR-B receptor in the rat spinal cord. FEBS Lett. 339: 168-170, 1994.
13. CUNNINGHAM, S. T. AND KELLEY, A. E.: Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens. J. Neurosci. 13: 2342-2350, 1993.
14. DESNOS, C., LARAN, M. P. AND SCHERMAN, D.: Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: Stimulus-biosynthesis coupling. J. Neurochem. 59: 2105-2112, 1992.
15. DICHIARA, G. AND IMPERATO, A.: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85: 5274-5278, 1988.
16. DIMARZO, V. AND PIOMELLI, D.: Participation of prostaglandin E2 in dopamine D2 receptor-dependent potentiation of arachidonic acid release. J. Neurochem. 59: 379-382, 1992.
17. DOUGHERTY, G G. J. AND ELLINWOOD, E. H.: Chronic d-amphetamine in nucleus aecumbens: Lack of tolerance or reverse tolerance of locomotor activity. Life Sci. 28: 2295-2298, 1981.
18. DOWNS, A. W. AND EDDY, N. B.: The effects of repeated injections of cocaine on the rat. J. Pharmacol. Exp. Ther. 46: 199-202, 1932.
19. EISON, A. S., EISON, M. S. AND IVERSEN, S. D.: The behavioral effects of a novel substance P analog following infusion into the ventral tegmental area or substantia nigra of the rat brain. Brain Res. 238: 137-152, 1982.
20. 1 that amplifies ATP-mediated arachidonic release. Proc. Natl. Acad. Sci. U.S.A. 88: 6477-6480, 1991.
21. FLETCHER, J. E., MICHAUX, K. AND JIANG, M.-S : Contribution of bee venom phospholipase A2 contamination in melittin fractions presumed to activation of tissue phospholipase A2. Toxicon 28: 647-656, 1990.
22. FONTANA, D. J., POST, R. M. AND PERT, A.: Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res. 629: 31-39, 1993.
23. RABERMANN, E.: Bee and wasp venoms. Science (Wash. DC) 177: 314-322, 1972.
24. HENRY, D. J., GREENE, M. A. AND WHITE, F. J : Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration. J. Pharmacol. Exp. Ther. 251: 833-839, 1989.
25. HENRY, D. J. AND WHITE, F. J.: Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus aceumbens J. Pharmacol. Exp. Ther. 258: 882-890, 1991.
26. HERNANDEZ, L. AND HOEBEL, B G.: Feeding enhances dopamine turnover in the prefrontal cortex. Brain Res. Bull. 25: 975-979, 1990.
27. HIBBELN, J. R., PALMER, J. W. AND DAVIS, J M.: Are disturbances in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness? Biol. Psychiatry 25: 945-961, 1989.
28. HIRATA, F , CORCORAN, B. AND VENKATASUBRAMANIA, K.: Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes. Proc. Natl. Acad. Sci. U.S.A. 76: 2640-2643, 1979.
29. IZUMI, Y , CLIFFORD, D B AND ZOBUMSKI, C. F : Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science (Wash. DC) 257: 1273-1276, 1992.
30. JOYCE, E. M. AND IVERSEN, S. D.: The effect of morphine applied locally to mesencephalic cell bodies on spontaneous motor activity in the rat. Neurosci. Lett. 14: 205-212, 1979.
31. KALIVAS, P. W. AND ALESDATTER, J.: Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267: 486-495, 1993.
32. KALIVAS, P. W. AND DUFFY, P : Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5: 48-58, 1990.
33. KALIVAS, P. W. AND DUFFY, P.: Time course of extracellular dopamine and behavioral sensitization to cocaine. I Dopamine axon terminals J Neurosci. 13: 266-275, 1993.
34. KALIVAS, P. W., DUFFY, P., DUMARS, L. A. AND SKINNER, C.: Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245: 485-492, 1988.
35. KALIVAS, P W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain. Res. Rev. 16: 223-244, 1991.
36. KALIVAS, P. W. AND WEBER, B.: Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245: 1095-1102, 1988.
37. KARLER, R., CALDER, L. D. AND BEDINGFIELD, J. B.: A dopaminergicglutamatergic basis for the action of amphetamine and cocaine Brain Res. 658: 8-14, 1994.
38. KARLER, R., CALDER, L D. AND TURKANIS, S. A., DNQX blockade of amphetamine behavioral sensitization. Brain Res 552: 295-300, 1991
39. KARLER, R.. FINNEGAN, K. T. AND CALDER, L. D.: Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res. 603: 19-24, 1993.
40. KARMAZYN, M., WATSON, J E. AND MOFFAT, M. P.: Mechanisms of cardiac depression induced by phorbol myristate acetate in working rat hearts. Br. J. Pharmacol. 100: 826-830, 1990.
41. KATO, K., CLARK, G D , BAZAN, N. G. AND ZORUMSKI, C F.: Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature (Lond) 367: 175-179, 1994.
42. KAZAHAYA, Y., AKIMOTO, K. AND OTSUKI, S.: Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo. Biol Psychiatry 25: 903-912, 1989
43. KELLER, R. W., MAISONNEUVE, I. M., CARLSON, J. N. AND GLICK, S. D.: Withinsubject sensitization of striatal dopamine release after a single injection of cocaine: An in vivo microdialysis study. Synapse 11: 28-34, 1992.
44. KEYSER, D. O. AND ALGER, B. E.: Arachidonic acid modulates hippoeampal calcium current via protein kinase C and oxygen radicals. Neuron 5: 543-553, 1990.
45. KOLTAI, M , HOSFORD, D., GUINOT, P., ESANU, A. AND BRAQUET, P.: Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I). Drugs 42: 9-29, 1991.
46. KOMBIAN, S. B. AND MALENKA, R. C.: Simultaneous LTP of non-NMDA and LTD of NMDA receptor-mediated responses in the nucleus accumbens. Nature (Lond.) 368: 242-246, 1994.
47. KORNECKI, E. AND EHRLICH, Y. H.: Neuroregulatory and neuropathological actions of ether phospholipid platelet activating factor. Science (Wash. DC) 240: 1792-1794, 1988.
48. LAZAREWICZ, J. W., SALINSKA, E. AND WROBLEWSKI, J. T.: NMDA receptor-mediated arachidonic acid release in neurons: Role in signal transduction and pathological aspects. Adv. Exp. Med Biol. 318: 73-89, 1992.
49. LISTER, M. D., GLASER, K. B., ULEVITCH, R. J. AND DENNIS, E. A: Inhibition studies on membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. J. Biol. Chem. 264: 8520-8528, 1989.
50. LYNCH, M. A., ERRINGTON, M. L. AND BLISS, T. V. P.: Nordihydroguaiaretic acid blocks the synaptic component of long-term potentiation and the associated increase in release of glutamate and arachidonate: An in vivo study in the dentate gyrus of the rat. Neuroscience 30: 693-701, 1989.
51. LYNCH, M. A. AND VOSS, K. L.: Arachidonic acid increases inositol phospholipids metabolism and glutamate release in synaptosome prepared from hippocampal tissue. J. Neurochem. 55: 215-221, 1990.
52. LYNCH, M A., VOSS, K. L., RODRIGUEZ, J. AND BLISS, T. V.: Increase in synaptic vesicle proteins accompanies long-term potentiation in the dentate gyrus. Neuroscience 60: 1-5, 1994.
53. MACLENNAN, A. J. AND MAIER, S. F.: Coping and the stress-induced potentiation of stimulant stereotypy in the rat. Science (Wash. DC) 219: 1091-1093, 1983.
54. MALENKA, R. C. AND NICOLL, R. A.: NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms. Trends Neurosci. 16: 521-527, 1993.
55. MAREN, S., Tocco, G., STANDLEY, S., BAUDRY, M. AND THOMPSON, R F.: Postsynaptic factors in the expression of long-term potentiation (LTP): Increased glutamate receptor binding following LTP induction in vivo. Proc. Natl. Acad. Sci. U.S.A. 90: 9654-9658, 1993.
56. MARK, G. P., SCHWARTZ, D. H , HERNANDEZ, L., WEST, H. L. AND HOEBEL, B. G.: Application of microdialysis to the study of motivation and conditioning: Measurements of dopamine and serotonin in freely behaving rats. In Microdialysis and the Neurosciences, ed. by T. E. Robinson and J. B. Justice, pp. 369-385, Elsevier Science Publishers, New York, 1991.
57. MASSICOTTE, G. AND BAUDRY, M.: Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment Neurosci. Lett. 118: 245-248, 1990.
58. MASSICOTTE, G., OLIVER, M. W., LYNCH, G. AND BAUDRY, M.: Effect of bromophenacyl bromide, a phospholipase A2 inhibitor, on the induction and maintenance of LTP in hippoeampal slices. Brain Res. 537: 49-53, 1990.
59. MOGHADDAM, B. AND BOLINAO, M. L.: Glutamatergic antagonists attenuate ability of dopamine uptake bloekers to increase extracellular levels of dopamine: Implications for tonic influence of glutamate on dopamine release. Synapse 18: 337-342, 1994.
60. MORRIS, R. G. M., ANDERSON, E , LYNCH, G. S. AND BAUDRY, M.: Selective impairment of learning and blockade of long-term potentiation by the N-methyl-D-aspartate receptor antagonist AP-5. Nature (Lond.) 319: 774-776, 1986.
61. 0a in discrete regions of the rat brain J. Neurochem. 55: 1079-1082, 1990.
62. NISHIYA, T.: Interaction of melittin and phospholipase A2 with azobenzecontainmg phospholipid. J. Biochem. 109: 383-388, 1991.
63. PAXINOS, G. AND WATSON, C.: The Rat Brain In Stereotaxic Coordinates, Academic Press, San Diego, 1986.
64. PIOMELLI, D. AND DIMARZO, V.: Dopamine D2 receptor signaling via the arachidonic acid cascade: Modulation by cAMP-dependent protein kinase A and prostaglandin E2. J Lipid Mediat. 6: 433-443, 1993.
65. POST, R. M. AND ROSE, H.: Increasing effects of repetitive cocaine administration in the rat. Nature (Lond.) 260: 731-732, 1976.
66. PUDIAK, C. M. AND BOZARTH, M. A : L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 53: 1517-1524, 1993.
67. RAY, P., BERMAN, J D, MIDDLETON, W. AND BRENDLE, J.: Botulinum toxin inhibits arachidonic acid release associated with acetylcholine release from PC12 cells. J. Biol. Chem 268: 11057-11064, 1993.
68. REID, M S., HERRERA-MARSCHITZ, M., HOKFELT, T., LINDEFORS, N., PERSSON, H. AND UNGERSTEDT, U.: Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: Evidence for direct regulatory mechanisms. Exp. Brian Res. 82: 293-303, 1990a.
69. REID, M. S., HERRERA-MARSCHITZ, M., KEHR, J. AND UNGERSTEDT, U.: Striatal dopamine and glutamate release: Effects of intranigral injections of substance P. Acta Physiol. Scand. 140: 527-537, 1990b.
70. ROBINSON, T. E. AND BECKER, J. B.: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. 396: 157-98, 1986
71. ROBINSON, T. E., Guo, H., Mo, O., SMITH, J. A., MAHER, J. R., WALLACE, M. J. AND KUNKO, P. M.: Cocaine increases extracellular aspartate and glutamate in rat nucleus accumbens. Soc. Neurosci. Abstr. 20: 222, 1994.
72. ROBINSON, T. E., JURSON, P A., BENNETT, J. A. AND BENTGEN, K. M.: Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res. 462: 211-222, 1988.
73. + channels in follicle-enclosed Xenopus oocytes. Eur. J Pharmacol. 252: 117-121, 1994.
74. 2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts. J. Pharmacol. Exp. Ther. 262: 1161-1167, 1992.
75. SARVEY, J. M.: Hippocampal long-term potentiation. In Sensitization in the Nervous System, ed. by P. W. Kalivas and C. D. Barnes, pp. 47-48, Telford Press, Caldwell, 1988.
76. SCHACHER, S., KANDEL, E R. AND MONTAROLO, P.: cAMP and arachidomc acid simulate long-term structural and functional changes produced by neurotransmitters in Aplysia sensory neurons Neuron 10: 1079-1088, 1993.
77. SCHAECHTER, J. D. AND BENOWITZ, L. I.: Activation of protein kinase C by arachidonic acid selectively enhances the phosphorylation of GAP-43 is nerve terminal membranes. J. Neurosci. 13: 4361-4371, 1993.
78. SCHINELLI, S., PAOLILLO, M. AND CORONA, G. L.: Opposing actions of D1- and D2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons. J. Neurochem. 62: 944-949, 1994.
79. SCHWARTZ, J. H. AND KANDEL, E. R : Synaptic transmission mediated by second messengers. In Principles of Neural Science, ed. by J. H. Schwartz, E. R. Kandel and T. M. Jessell, pp. 173-193, Elsevier, New York, 1991.
80. SHEPHERD, N., KAVALER, F. AND SPIELMAN, W.: Cadmium block of isometric contractions of isolated bullfrog atrial cells. Am. J. Physiol. 260: C249-C258, 1991.
81. STEKETEE, J. D. AND KALIVAS, P. W.: Sensitization to psychostimulants and stress after injection of pertussis toxin into the AlO dopamine region J. Pharmacol. Exp. Ther. 259: 916-924, 1991.
82. STEWART, J. AND VEZINA, P : Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the loeomotor activating effects of systemic amphetamine Brain Res. 495: 401-406, 1989.
83. STRIPLIN, C. D. AND KALIVAS, P. W.: Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res. 579: 181-186, 1992.
84. TOLLIVER, B K., BELKNAP, J. K., WOODS. W. E. AND CARNEY, J. M : Genetic analysis of sensitization and tolerance to cocaine J. Pharmacol. Exp. Ther 270: 1230-1238, 1994.
85. TORDA, T., YAMAGUCHI, I., HIRATA, P , KOPIN, I. J. AND AXELROD, J.: Quinacrineblocked desensitization of adrenoceptors after immobilization stress or repeated injection of isoproterenol in rats. J. Pharmacol. Exp. Ther. 216: 334-338, 1981.
86. VEZINA, P.: Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat. Brain Res. 605: 332-337, 1993.
87. VEZINA, P. AND STEWART, J.: Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects. Brain Res. 516: 99-106, 1990.
88. VOLTERRA, A., TROTTI, D., CASSUTTI, P., TROMBA, C., SALVAGGIO, A. AND MELCANGI, R.: High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J Neurochem. 59: 600-609, 1992.
89. WITKIN, J. M.: Blockade of the locomotor stimulator effects of cocaine and methamphetamine by glutamate antagonists Life Sci. 53: PL405-PL410, 1993.
90. WOLF, M. E., WHITE, F. J., NASSAR, R., BROODERSON, R. J. AND KHANSA, M. R.: Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255, 1993.
91. YUE, T.-L., GLEASON, M. M., GU, J.-L , LYSKO, P. G., HALLEN, J. AND FEUERSTEIN, G.: Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: Studies with BN50739, a new PAF antagonist. J. Pharmacol. Exp Ther. 257: 374-381, 1991.
92. ZETTERSTRÖM, T., HERRERA-MARSCHITZ, M. AND UNGERSTEDT, U.: Simultaneous measurement of dopamine release and rotational behavior in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 376: 1-7, 1986